| 1 |
25621797 | High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant. | 2015 Apr |
1 |
| 2 |
21042310 | TBI and melphalan followed by allogeneic hematopoietic SCT in children with advanced hematological malignancies. | 2011 Aug |
1 |
| 3 |
18999930 | Polyethylene glycol conjugates of methotrexate and melphalan: synthesis, radiolabeling and biologic studies. | 2008 Oct |
1 |
| 4 |
17176891 | [Cryotherapy is useful and safe in the prevention of oral mucositis after high-dose melphalan (L-PAM)]. | 2006 Nov |
1 |
| 5 |
14761920 | Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-alpha and melphalan for bulky in-transit melanoma metastases. | 2004 Feb |
1 |
| 6 |
12189530 | Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy. | 2002 Aug |
1 |
| 7 |
11878777 | Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line. | 2001 Nov |
1 |
| 8 |
10789721 | Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. | 2000 May |
2 |
| 9 |
11079271 | Allograft with unrelated donor accentuates the gastrointestinal toxicity associated with high-dose melphalan and total body irradiation preparative for bone marrow transplantation in children. | 2000 Nov |
1 |
| 10 |
9548610 | Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases? | 1998 Apr-May |
1 |
| 11 |
9670271 | Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases. | 1998 |
1 |
| 12 |
9679558 | L-S,R-buthionine sulfoximine: historical development and clinical issues. | 1998 Apr 24 |
2 |
| 13 |
9951688 | Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration. | 1998 Dec |
1 |
| 14 |
9329556 | Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease. | 1997 Jul-Aug |
1 |
| 15 |
9516845 | Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. | 1997 Oct |
2 |
| 16 |
7622292 | Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line. | 1995 Jul 17 |
1 |
| 17 |
8004757 | In vivo modulation of several anticancer agents by beta-carotene. | 1994 |
1 |
| 18 |
2208589 | DNA adenine adducts induced by nitrogen mustards and their role in transcription termination in vitro. | 1990 Oct |
1 |
| 19 |
2260990 | Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent. | 1990 Dec 15 |
1 |
| 20 |
3178239 | [Reduced cisplatin-uptake by cisplatin-resistant human ovarian cancer cells]. | 1988 Oct |
1 |
| 21 |
3182309 | Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma. | 1988 Oct |
1 |
| 22 |
3349564 | A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma. | 1988 |
1 |
| 23 |
3497748 | Differences in sensitivity to melphalan between con A-activated and nonactivated human T-cell subsets. | 1987 Oct |
1 |
| 24 |
6434498 | Chemopotentiation by CB 1954: the importance of postincubations and the possible involvement of poly(ADP-ribosylation). | 1984 Sep |
1 |
| 25 |
6541216 | Modification of alkylating agent cytotoxicity by cisplatin. | 1984 Sep |
1 |
| 26 |
6546359 | Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer. | 1984 Feb 15 |
1 |
| 27 |
6882665 | Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole. | 1983 Aug |
1 |
| 28 |
7000345 | L-phenylalanine mustard (L-PAM): the first 25 years. | 1980 Apr-May |
1 |
| 29 |
536450 | Application of a simple high-performance liquid chromatographic method for the determination of melphalan in the presence of its hydrolysis products. | 1979 Sep 14 |
1 |
| 30 |
101843 | Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. | 1978 Dec 7 |
1 |
| 31 |
1016968 | Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. | 1976 Sep |
1 |